Tunisia Bars Family, Lawyers From Seeing Ghannouchi After Prison Collapse
Tunisian authorities have barred family members and lawyers from visiting jailed opposition leader Rached Ghannouchi following what his family describes as a collapse inside the prison where he is held, Al Jazeera reports. His son told the outlet there has been no word on his father's condition for 11 days. The family is demanding immediate access and information on his health.
Tunisian authorities have barred family members and lawyers from visiting jailed opposition leader Rached Ghannouchi, according to Al Jazeera, following what his relatives describe as a collapse inside the prison where he is held. His son told Al Jazeera the family has had no word on his father's condition for 11 days.
The elder Ghannouchi, who leads the Ennahda party, has been imprisoned since 2023 on charges his supporters say are politically motivated. Family members say repeated requests to visit him or obtain information from prison officials since the reported collapse have gone unanswered, leaving them unable to confirm his health or whereabouts.
Al Jazeera reports the family is calling for immediate access to Ghannouchi and full disclosure of his medical condition. There has been no official statement from Tunisian prison authorities on the reported incident or the restrictions on visits, according to the family's account relayed to the outlet.
Read next
Iran-Backed Houthis Claim Missile Attack on Saudi Arabia
Yemen's Houthi movement, described by the BBC as Iran-backed, said on Monday it had fired a missile at Saudi Arabia, as the U.S. military reported disabling a tanker attempting to evade its blockade on Iranian ports. Neither Riyadh nor Washington has confirmed the scale of the reported strike. The claims add to a string of recent incidents across the Gulf and Red Sea.
China's Moonshot AI stole from Anthropic, Trump tech adviser says
South Africa investigates death of Nigerian man who collapsed during arrest
DRC Ebola outbreak deaths reach 1,405 as Oxford launches vaccine trial
